TARO
$73.24
Taro Pharm Inds
$.29
.40%
TARO
Earnings Whisper ®
N/A
4th Quarter March 2020
Consensus:  $1.53
Revenue:  $168.25 Mil
Monday
May 4
5:20 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, February 3, 2020

What do you expect when TARO reports earnings?
Beat
Meet
Miss

Where is TARO's stock price going from here?
Up
Flat
Down
Stock chart of TARO
Analysts
Summary of analysts' recommendations for TARO
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.